Publications by authors named "Line Uhrenholt"

Claim this Profile
E
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
Line Uhrenholt, Mads E R Sørensen, Karen B Lauridsen, Kirsten Duch, Lene Dreyer

Rheumatol Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Tue Wenzel Kragstrup, Kristine Jagd Ottosen, Line Uhrenholt, Emil Barner Dalgaard

Ugeskr Laeger· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial.
Line Uhrenholt, Kirsten Duch, Robin Christensen, Lene Dreyer, Ellen-Margrethe Hauge

Br J Clin Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Mikkel Østergaard, Ronald F van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Line Uhrenholt

Ann Rheum Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis.
Line Uhrenholt, Robin Christensen, Wilfred K H Dinesen, Caroline H Liboriussen, Stine S Andersen

Rheumatology (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey.
Tobias Eschricht Eriksen, Wilfred K H Dinesen, Line Uhrenholt, Lene Dreyer, Kirsten Duch

Rheumatol Int· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
Line Uhrenholt, Simone Høstgaard, Julie F Pedersen, Robin Christensen, Lene Dreyer

Lupus· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
René Cordtz, Jesper Lindhardsen, Bolette G Soussi, Jonathan Vela, Line Uhrenholt

Rheumatology (Oxford)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Merete Lund Hetland, Espen A Haavardsholm, Anna Rudin, Dan Nordström, Michael Nurmohamed, Line Uhrenholt

BMJ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial).
Line Uhrenholt, Annette Schlemmer, Ellen-Margrethe Hauge, Robin Christensen, Lene Dreyer

BMJ Open· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Acute abdominal vasculitis in rheumatic diseases].
Line Uhrenholt, Lars S Jensen, Thomas S Jakobsen, Salome Kristensen, Jens Frederik Dahlerup

Ugeskr Laeger· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis